AstraZeneca Covid-19 vaccine shows 74pc efficacy in large US trial

CHICAGO, Sept 30 — AstraZeneca Plc’s Covid-19 vaccine demonstrated 74 per cent efficacy at preventing symptomatic disease, a figure that increased to 83.5 per cent in people aged 65 and older, according to long-awaited results of the…